<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
AXGN
AxoGen
$
()


  • AxoGen files $100M mixed securities shelf

    3/6/2024 - 08:54am
  • AxoGen sees FY24 revenue $177M-$181M, consensus $178.85M

    3/5/2024 - 07:12am
  • AxoGen reports Q4 adjusted EPS (6c), consensus (10c)

    3/5/2024 - 07:11am
  • Fly Intel: After-Hours Movers

    1/18/2024 - 18:04pm
  • AxoGen announces results from REPOSE clinical study

    1/18/2024 - 17:01pm
  • Fly Intel: Pre-market Movers

    1/5/2024 - 09:02am
  • Fly Intel: After-Hours Movers

    1/4/2024 - 18:09pm
  • AxoGen raises 2023 revenue view to upper end of $154M-$159M view

    1/4/2024 - 16:49pm
  • AxoGen sees Q4 revenue $42.7M, consensus $40.68M

    1/4/2024 - 16:48pm
  • AxoGen CEO Karen Zaderej to retire from company by January 2025

    1/4/2024 - 16:41pm
  • AxoGen reaffirms FY23 revenue $154M-$159M, consensus $156.75M

    12/6/2023 - 07:12am
  • AxoGen appoints Naor as Chief Financial Officer

    12/6/2023 - 07:12am
  • J.Jill appointa Maria Martinez as CHRO

    11/13/2023 - 06:50am
  • AxoGen price target lowered to $17 from $20 at JMP Securities

    11/8/2023 - 09:22am
  • AxoGen price target lowered to $11 from $15 at Canaccord

    11/8/2023 - 07:18am
dynamic_feed Breaking News